Reuters Events | Pharma

Thought leadership and innovation for the Pharmaceutical Industry

We recently sat down with Brian Nugent, Associate Director, ClinOps Process at Gilead Sciences. He shared his experience with designing a successful framework on how QbD (Quality by Design) can be integrated into the risk mitigation management model and how to realize an optimal return from RBM (Risk Based Monitoring).

Gain these insights and get your copy now